SLTX

LIVE

Serial Number

88197578

Owner

Sigilon Therapeutics, Inc.

Attorney

John R. Rudolph

First Use Date

Sep 17, 2020

Filing Date

Nov 16, 2018

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

SLTX Trademark

Serial Number: 88197578 • Registration: 6201037

SLTX is a trademark filed by Sigilon Therapeutics, Inc. on November 16, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 1 - Chemicals

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Sigilon Therapeutics, Inc. (8 trademarks)

100 Binney Street, Suite 600
Cambridge, MA 02142

Entity Type: 03

Legal Representation

Attorney of Record

John R. Rudolph

122 trademarks filed View all →

Correspondence Address

John R. Rudolph Eli Lilly and Company

Lilly Corporate Center

www.lilly.com

Indianapolis, IN 46285

United States

Trademark Details

Filing Date

November 16, 2018

Registration Date

November 17, 2020

First Use Anywhere

September 17, 2020

First Use in Commerce

September 17, 2020

Published for Opposition

April 9, 2019

Goods & Services

Chemical, pharmaceutical, biopharmaceutical and biomedical agents for medical use, namely, pharmaceutical agents for modulating immune response; chemical agents for pharmaceutical or medical purposes, namely, pharmaceutical agents for modulating immune response; pharmaceutical agents for encapsulating transplanted cells to prevent the risk of rejection from immune attack, for medical purposes; pharmaceutical preparations for the prevention and treatment of fibrosis, inflammation, cancer or infection; drug delivery agents in the form of coatings for capsules that facilitate the tolerance and delivery of pharmaceutical preparations; chemical agents, namely, drug delivery agents in the form of coatings that facilitate the delivery of pharmaceutical agents and cells

Chemical agents for coating of medical devices and medical materials; reagents for research purposes; reagents for scientific or medical research use

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Nov 17, 2025 REM1

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Mar 18, 2024 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Mar 18, 2024 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Mar 18, 2024 REAP

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Mar 18, 2024 CHAN

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Mar 18, 2024 COAR

REGISTERED-PRINCIPAL REGISTER

Nov 17, 2020 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Oct 14, 2020 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Oct 13, 2020 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Oct 7, 2020 SUPC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Oct 7, 2020 AITU

USE AMENDMENT FILED

Sep 23, 2020 IUAF

TEAS STATEMENT OF USE RECEIVED

Sep 23, 2020 EISU

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

May 21, 2020 EXRA

SOU EXTENSION 2 GRANTED

May 19, 2020 EX2G

SOU EXTENSION 2 FILED

May 19, 2020 EXT2

SOU TEAS EXTENSION RECEIVED

May 19, 2020 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Nov 6, 2019 EXRA

SOU EXTENSION 1 GRANTED

Nov 4, 2019 EX1G

SOU EXTENSION 1 FILED

Nov 4, 2019 EXT1

SOU TEAS EXTENSION RECEIVED

Nov 4, 2019 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 4, 2019 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 9, 2019 NPUB

PUBLISHED FOR OPPOSITION

Apr 9, 2019 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 20, 2019 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 25, 2019 CNSA

ASSIGNED TO EXAMINER

Feb 20, 2019 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Dec 4, 2018 NWOS

NEW APPLICATION ENTERED

Nov 20, 2018 NWAP

Related Trademarks

More from this Owner

SHIELDED LIVING THERAPEUTICS

LIVING THERAPEUTICS FOR LIFE

LIVING THERAPEUTICS

More in Same Class